Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C
- 1 February 1990
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 18 (2) , 375-382
- https://doi.org/10.1016/0360-3016(90)90103-q
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA®/carbogen/radiationRadiotherapy and Oncology, 1990
- A phase I–II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignanciesInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignanciesInternational Journal of Hyperthermia, 1988
- The role of mitomycin antibiotics in the chemotherapy of solid tumorsBiochemical Pharmacology, 1986
- Tumour microcirculation as a target for hyperthermiaInternational Journal of Hyperthermia, 1986
- Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumoursBritish Journal of Cancer, 1985
- Cell selection from a murine tumour using the fluorescent probe Hoechst 33342British Journal of Cancer, 1985
- Perfluorochemical Emulsions Can Increase Tumor RadiosensitivityScience, 1984
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980
- Effects of adriamycin and x-rays on euoxic and hypoxic EMT-6 cells in vitroInternational Journal of Radiation Oncology*Biology*Physics, 1979